Protease inhibitors and adverse birth outcomes: is progesterone the missing piece to the puzzle?

J Infect Dis. 2015 Jan 1;211(1):4-7. doi: 10.1093/infdis/jiu397. Epub 2014 Jul 16.

Authors

Kathleen M Powis¹, Roger L Shapiro²

Affiliations

¹ Departments of Internal Medicine and Pediatrics, Massachusetts General Hospital Department of Immunology and Infectious Diseases, Harvard School of Public Health.
² Department of Immunology and Infectious Diseases, Harvard School of Public Health Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

PMID: 25030057
DOI: 10.1093/infdis/jiu397

No abstract available

Keywords: HIV; pregnancy outcomes; progesterone; protease inhibitors.

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Animals
Female
Fetal Development / drug effects*
Fetal Growth Retardation / chemically induced*
HIV Infections / drug therapy*
HIV Protease Inhibitors / adverse effects*
HIV Protease Inhibitors / therapeutic use*
Humans
Male
Pregnancy
Pregnancy Complications, Infectious / drug therapy*
Progesterone / metabolism*

Substances

HIV Protease Inhibitors
Progesterone

Grants and funding